KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Cash & Current Investments: 2018-2025

Historic Cash & Current Investments for Aurinia Pharmaceuticals (AUPH) over the last 8 years, with Sep 2025 value amounting to $351.8 million.

  • Aurinia Pharmaceuticals' Cash & Current Investments rose 0.88% to $351.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year decrease of 0.84%. This contributed to the annual value of $358.5 million for FY2024, which is 2.28% up from last year.
  • Per Aurinia Pharmaceuticals' latest filing, its Cash & Current Investments stood at $351.8 million for Q3 2025, which was up 11.64% from $315.1 million recorded in Q2 2025.
  • In the past 5 years, Aurinia Pharmaceuticals' Cash & Current Investments ranged from a high of $466.1 million in Q4 2021 and a low of $286.4 million during Q3 2021.
  • In the last 3 years, Aurinia Pharmaceuticals' Cash & Current Investments had a median value of $348.7 million in 2024 and averaged $339.8 million.
  • Examining YoY changes over the last 5 years, Aurinia Pharmaceuticals' Cash & Current Investments showed a top increase of 59.01% in 2021 and a maximum decrease of 26.95% in 2021.
  • Quarterly analysis of 5 years shows Aurinia Pharmaceuticals' Cash & Current Investments stood at $466.1 million in 2021, then fell by 16.45% to $389.4 million in 2022, then fell by 9.99% to $350.5 million in 2023, then rose by 2.28% to $358.5 million in 2024, then grew by 0.88% to $351.8 million in 2025.
  • Its Cash & Current Investments was $351.8 million in Q3 2025, compared to $315.1 million in Q2 2025 and $312.9 million in Q1 2025.